The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, current, and standardized dataset on the cost of delivering vaccines in low- and middle-income countries. It was built to answer a question frequently asked by national and global immunization stakeholders: “What are the unit costs of vaccine delivery across different low- and middle-income countries and through a variety of delivery strategies?”
First developed in 2017 by ThinkWell under the Immunization Cost Action Network (ICAN) project, the IDCC was updated in 2018, 2019 and most recently in 2024. The IDCC is based on a systematic review of the current evidence base on immunization delivery costs: over 22,000 resources published between January 2005 to December 2023 were reviewed and immunization delivery cost evidence was extracted from over 100 journal articles and grey literature reports.
Standardized and richly annotated Excel-based cost catalogue. Includes cost per dose delivered, cost per target person, and cost per vaccinated person, in 2022 US$. Last updated in May 2024, includes journal articles and reports from January 2005–December 2023.
This brief presents a descriptive analysis of the IDCC, showing what evidence on the cost of immunization delivery is available and what are the current evidence gaps. The brief also illustrates delivery cost per dose for routine and supplementary immunization activities (SIAs), key antigens, delivery strategies, and target populations.
This document presents a description of each variable included in the latest version of the IDCC as well as the definition of key immunization delivery cost terms.
This document outlines the methodology for the 2024 systematic review and update of the IDCC.
Updated in 2019, this version covered journal articles and reports from January 2005–March 2019.
Updated 2018, this version covered journal articles and reports from January 2005–April 2018.
For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.
Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.
Donate
